Actuate Therapeutics, Inc. Common stock (ACTU) — Financial Flexibility Index
Actuate Therapeutics, Inc. Common stock (ACTU) has a Financial Flexibility Index of -0.99x as of September 2025. Free cash flow of $-6.68 Million (operating CF $-6.68 Million minus capex $3.00) represents -1% of total liabilities ($6.78 Million). Also explore ACTU year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Actuate Therapeutics, Inc. Common stock Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Actuate Therapeutics, Inc. Common stock across 3 annual periods. See Actuate Therapeutics, Inc. Common stock balance sheet independence to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Actuate Therapeutics, Inc. Common stock (2022–2024)
Year-by-year free cash flow to debt coverage for Actuate Therapeutics, Inc. Common stock. For the full company profile including market capitalisation, see ACTU company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.37x | $-21.84 Million | $-21.84 Million | $9.21 Million | ▼ -1024.9% |
| 2023 | -0.21x | $-21.63 Million | $-21.63 Million | $102.62 Million | ▲ +93.3% |
| 2022 | -3.15x | $-17.79 Million | $-17.79 Million | $5.65 Million | — |